韦瑞西瓜特在甲回的老鼠模型中保留了心脏功能和线粒体质量
Peeraya Jungtanasomboon1, Surunchana Nussaro1, Hathaichanok Winwan1
1Department of Physiology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand.
Life sciences
|July 12, 2023
概括
一种新型心力衰竭药物Vericiguat通过提高线粒体质量,改善了心脏功能,降低了血压,并降低了米特拉吐的老鼠的纤维化.
科学领域:
- 心血管研究研究心血管研究
- 药理学 药理学是指药理学的学科.
- 线粒体生物学 线粒体生物学
背景情况:
- 心力衰竭 (HF) 治疗策略正在发展,重点是针对NO-sGC-cGMP途径的新药.
- 慢性 mitra 吐 (MR) 会导致显著的心脏功能障碍和重塑.
研究的目的:
- 评估一种可溶性瓜尼酸环酶 (sGC) 刺激剂的 vericiguat 在慢性MR的老鼠模型中的疗效.
- 评估输送器对心脏功能,血压,线粒体质量和心脏纤维化的影响.
主要方法:
- 在Sprague-Dawley大鼠中手术诱导MR,用假操作的对照.
- 在MR大鼠中,给予达西瓜特 (0.5毫克/公斤/天) 或安慰剂8周.
- 心声学,血压监测和心脏组织分析以检测纤维化和线粒体功能.
主要成果:
- 韦瑞西瓜特治疗在MR大鼠中保留了心脏功能和减弱了结构重塑.
- 显著降低缩血压和降低心脏纤维化被观察到与 vericiguat.
- 韦里西瓜特通过减少活性氧物种 (ROS) 生产,脱极化和胀来改善线粒体质量.
结论:
- 韦里西瓜特在由MR引起的心力衰竭的小鼠模型中表现出显著的心脏保护作用.
- 药物的益处与改善心脏线粒体质量,减少纤维化和血压调节有关.
相关概念视频
Mitral Regurgitation III: Medical Management
19
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
19
Mitral Regurgitation I: Introduction
18
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
18
Mitral Regurgitation IV: Nursing Management
50
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
50
Mitral Stenosis III: Medical Management
13
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
13
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
24
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
24


